Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A11QVV0
Thu, 08.10.2020
Heidelberg Pharma AG
Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2020
- IND application to the FDA for the Phase I/IIa clinical trial of HDP-101 in preparation
- Private placement with gross proceeds of EUR 14.4 million and further financing commitment of EUR 15 million by majority shareholder dievini received
- Expansion of own AT [ … ]
Mon, 14.09.2020
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Receives Milestone Payment from Partner Magenta
Ladenburg, Germany, 14 September 2020 - Heidelberg Pharma AG (FSE: HPHA) announced today that it has received a milestone payment from its cooperation partner Magenta Therapeutics, Cambridge, MA, USA, (Magenta) (NASDAQ: MGTA) associated with the initiation of the GLP [ … ]
Thu, 10.09.2020
Heidelberg Pharma AG
PRESS RELEASE
Heidelberg Pharma Announces Participation at Various Conferences
Ladenburg, Germany, 10 September 2020 - Heidelberg Pharma AG (FSE: HPHA) today announced that they will participate at the following events. Heidelberg Pharma is an oncology specialist and the first company to develop the toxin Amanitin into cancer therapies using its [ … ]